Fig. 3From: An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma a Prognostic impact of the 18-gene Stage4NB risk score, MYCN amplification and age ≥18 months. b Kaplan–Meier estimates of the rate of survival at 5-years according to combination of the 18-gene Stage4NB risk score, MYCN and ageBack to article page